Analysts’ Viewpoint on Market Scenario
Increase in the prevalence of epilepsy and anxiety disorders is driving the global vagus nerve stimulator market size. Vagus Nerve Stimulation (VNS) devices send mild electrical impulses to the vagus nerve for the treatment of epilepsy and depression. Vagus nerve stimulators are also used for the treatment of anxiety disorders, migraines, and cluster headaches.
R&D of advanced and effective vagus nerve stimulators is expected to augment market expansion during the forecast period. Noninvasive vagus nerve stimulation devices do not require surgical implantation. Thus, vagus nerve stimulator manufacturers are launching advanced non-invasive VNS devices to broaden their revenue share.
Vagus nerve stimulator is a medical device that is used to stimulate the vagus nerve ‒ a cranial nerve that runs from the brainstem to the abdomen. VNS can effectively reduce the frequency of seizures in patients with epilepsy. It can also mitigate symptoms of depression and anxiety in some patients.
However, VNS is not a cure-all and may not be effective for everyone. It is important to discuss the potential risks and benefits of VNS with a healthcare provider before considering this treatment option.
Request a sample to get extensive insights into the Vagus Nerve Stimulator Market
VNS is widely employed for the treatment of epilepsy. Genetic factors, head injuries, strokes, brain tumors, and infectious diseases are various factors that can contribute to the development of epilepsy.
According to a study conducted by the International League Against Epilepsy (ILAE), VNS is effective in reducing seizures in a subset of patients with epilepsy.
Additionally, it may be a useful adjunctive treatment for patients who have not responded to other therapies. Increase in the geriatric population is anticipated to fuel market development in the next few years. People above 65 years of age are at high risk of epilepsy, head injuries, and strokes.
Technological advancements have led to the development of more effective vagus nerve stimulators. These devices can be tailored to specific patient needs and deliver precise, targeted stimulation to the vagus nerve. Vendors in the industry are launching compact and portable products to expand their vagus nerve stimulator market share.
Vagus nerve stimulators developed with advanced technologies facilitate a more personalized treatment approach. They can also be more effective in reducing the frequency and severity of certain conditions. Manufacturers are incorporating IoT features, such as Bluetooth connectivity and smartphone app integration, to enable remote monitoring services and adjustment of stimulation settings. Therefore, the availability of IoT-enabled products is likely to propel market statistics in the near future.
Request a custom report on Vagus Nerve Stimulator Market
According to the latest market trends, the implantable product type segment held the largest share of the industry in 2021. Implantable vagus nerve stimulators are generally considered safe and effective with surgical procedures.
Additionally, the development of more advanced and effective implantable vagus nerve stimulators and the incorporation of IoT features have contributed to growth of the segment. Implementation of favorable reimbursement policies for implantable vagus nerve stimulators is also driving the segment.
The epileptic seizures application segment held largest share of the vagus nerve stimulator market in 2021. Rise in awareness about epilepsy and related treatments is boosting the segment. Moreover, adoption of new guidelines and the availability of funding for the treatment of epileptic seizures is also driving the segment.
The hospitals end-user segment dominated the industry in 2021. This can be ascribed to the availability of a robust hospital infrastructure and surge in preference for hospitals for chronic epilepsy treatment. Rise in healthcare expenditure and increase in access to implantable vagus nerve stimulators are also augmenting the segment.
North America is expected to account for major share of the industry during the forecast period. Surge in government funding and increase in awareness about epilepsy and depression are driving market revenue in the region.
The market in Asia Pacific is projected to grow at a rapid pace during 2022-2031. High prevalence of depression, anxiety, epilepsy, and obesity is contributing to the vagus nerve stimulator industry growth in the region. Several governments in Asia Pacific are investing significantly in healthcare infrastructure development.
Organizations such as The Asia-Pacific Centre for Neuromodulation (APCN) are at the forefront of boosting adoption of Deep Brain Stimulation devices (DBS) for the treatment of neurological diseases in the region.
The industry is highly consolidated, with the presence of a small number of dominant vendors. Most companies adopt strategic alliances to broaden their revenue and market share. The vagus nerve stimulator market report profiles leading players based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.
ReShape Lifesciences, Inc., LivaNova LLC, electroCore, Inc., MicroTransponder Inc., Parasym Ltd., Cerebral Inc., Cerbomed GmbH, Neuvana, LLC, Nevro Corp., and NeuroPace Inc. are key entities operating in the industry.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 444.7 Mn |
|
Forecast (Value) in 2031 |
More than US$ 1.1 Bn |
|
Growth Rate (CAGR) for 2022-2031 |
10.1% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Mn/Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
It was valued at US$ 444.7 Mn in 2021.
It is projected to reach more than US$ 1.1 Bn by 2031.
It is anticipated to be 10.1% from 2022 to 2031.
Increase in prevalence of epilepsy and anxiety disorders and R&D of advanced and effective vagus nerve stimulators.
North America is expected to account for major share during the forecast period.
ReShape Lifesciences, Inc., LivaNova LLC, electroCore, Inc., MicroTransponder Inc., Parasym Ltd., Cerebral Inc., Cerbomed GmbH, Neuvana, LLC, Nevro Corp., and NeuroPace Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Vagus Nerve Stimulator Market
4. Market Overview
4.1. Introduction
4.1.1. Segmentation Definition
4.1.2. Industry Evolution /Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vagus Nerve Stimulator Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/Globally
5.3. Pricing Analysis
5.4. COVID-19 Impact Analysis
6. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Implantable
6.3.2. Non-invasive (tVNS)
6.4. Market Attractiveness Analysis, By Product Type
7. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Biomaterial, 2017–2031
7.3.1. Ceramics
7.3.2. Metallic
7.3.3. Polymeric
7.4. Market Attractiveness Analysis, By Biomaterial
8. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Pain Management
8.3.2. Epileptic Seizures
8.3.3. Depression and Anxiety
8.3.4. Obesity Management
8.3.5. Others
8.4. Market Attractiveness Analysis, By Application
9. Global Vagus Nerve Stimulator Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers (ASCs)
9.3.3. Others
9.4. Market Attractiveness Analysis, By End-user
10. Global Vagus Nerve Stimulator Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, By Region
11. North America Vagus Nerve Stimulator Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Implantable
11.2.2. Non-invasive (tVNS)
11.3. Market Value Forecast, by Biomaterial, 2017–2031
11.3.1. Ceramics
11.3.2. Metallic
11.3.3. Polymeric
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Pain Management
11.4.2. Epileptic Seizures
11.4.3. Depression and Anxiety
11.4.4. Obesity Management
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers (ASCs)
11.5.3. Others
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Biomaterial
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Vagus Nerve Stimulator Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Implantable
12.2.2. Non-invasive (tVNS)
12.3. Market Value Forecast, by Biomaterial, 2017–2031
12.3.1. Ceramics
12.3.2. Metallic
12.3.3. Polymeric
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Pain Management
12.4.2. Epileptic Seizures
12.4.3. Depression and Anxiety
12.4.4. Obesity Management
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers (ASCs)
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Biomaterial
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Implantable
13.2.2. Non-invasive (tVNS)
13.3. Market Value Forecast, by Biomaterial, 2017–2031
13.3.1. Ceramics
13.3.2. Metallic
13.3.3. Polymeric
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Pain Management
13.4.2. Epileptic Seizures
13.4.3. Depression and Anxiety
13.4.4. Obesity Management
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers (ASCs)
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Biomaterial
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Vagus Nerve Stimulator Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Implantable
14.2.2. Non-invasive (tVNS)
14.3. Market Value Forecast, by Biomaterial, 2017–2031
14.3.1. Ceramics
14.3.2. Metallic
14.3.3. Polymeric
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Pain Management
14.4.2. Epileptic Seizures
14.4.3. Depression and Anxiety
14.4.4. Obesity Management
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers (ASCs)
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Biomaterial
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Implantable
15.2.2. Non-invasive (tVNS)
15.3. Market Value Forecast, by Biomaterial, 2017–2031
15.3.1. Ceramics
15.3.2. Metallic
15.3.3. Polymeric
15.4. Market Value Forecast, by Application, 2017–2031
15.4.1. Pain Management
15.4.2. Epileptic Seizures
15.4.3. Depression and Anxiety
15.4.4. Obesity Management
15.4.5. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers (ASCs)
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Biomaterial
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company, 2021
16.3. Company Profiles
16.3.1. ReShape Lifesciences, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. LivaNova LLC
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Strategic Overview
16.3.3. electroCore, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. MicroTransponder Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Strategic Overview
16.3.5. Parasym Ltd.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. Cerebral Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Strategic Overview
16.3.7. Cerbomed GmbH
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
16.3.8. Neuvana, LLC
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Strategic Overview
16.3.9. Nevro Corp.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. NeuroPace Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Strategic Overview
List of Tables
Table 01: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031
Table 03: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031
Table 04: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 05: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 08: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031
Table 09: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031
Table 10: North America Vagus Nerve Stimulator Market) Forecast, by Biomaterial, 2017–2031
Table 11: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 14: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031
Table 16: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031
Table 17: Europe Vagus Nerve Stimulator Market Forecast, by Biomaterial, 2017–2031
Table 18: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 19: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 20: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 22: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031
Table 23: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031
Table 24: Asia Pacific Vagus Nerve Stimulator Market, by Biomaterial, 2017–2031
Table 25: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 26: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 27: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 28: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 29: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031
Table 30: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031
Table 31: Latin America Vagus Nerve Stimulator Market Forecast, by Biomaterial, 2017–2031
Table 32: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 33: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 34: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 35: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 36: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Implantable, 2017–2031
Table 37: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Biomaterial, 2017–2031
Table 38: Middle East & Africa Vagus Nerve Stimulator Market Forecast, by Biomaterial, 2017–2031
Table 39: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 40: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 41: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Vagus Nerve Stimulator Market Value Share, by Product Type (2021)
Figure 03: Global Vagus Nerve Stimulator Market Value Share, by Biomaterial (2021)
Figure 04: Global Vagus Nerve Stimulator Market Value Share, by Application (2021)
Figure 05: Global Vagus Nerve Stimulator Market Value Share, by End-user (2021)
Figure 06: Global Vagus Nerve Stimulator Market Value Share, by End-user (2021)
Figure 07: Global Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 08: Global Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 09: Global Vagus Nerve Stimulator Market (US$ Mn), by Implantable, 2017–2031
Figure 10: Global Vagus Nerve Stimulator Market (US$ Mn), by Non-invasive (tVNS), 2017-2031
Figure 11: Global Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031
Figure 12: Global Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031
Figure 13: Global Vagus Nerve Stimulator Market (US$ Mn), by Ceramics, 2017–2031
Figure 14: Global Vagus Nerve Stimulator Market (US$ Mn), by Metallic, 2017-2031
Figure 15: Global Vagus Nerve Stimulator Market (US$ Mn), by Polymeric, 2017-2031
Figure 16: Global Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031
Figure 17: Global Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031
Figure 18: Global Vagus Nerve Stimulator Market (US$ Mn), by Pain Management, 2017–2031
Figure 19: Global Vagus Nerve Stimulator Market (US$ Mn), by Epileptic Seizures, 2017-2031
Figure 20: Global Vagus Nerve Stimulator Market (US$ Mn), by Depression and Anxiety, 2017–2031
Figure 21: Global Vagus Nerve Stimulator Market (US$ Mn), by Others, 2017-2031
Figure 22: Global Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 23: Global Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031
Figure 24: Global Vagus Nerve Stimulator Market (US$ Mn), by Hospitals, 2017–2031
Figure 25: Global Vagus Nerve Stimulator Market (US$ Mn), by Ambulatory Surgical Centers (ASCs), 2017-2031
Figure 26: Global Vagus Nerve Stimulator Market (US$ Mn), by Others, 2017-2031
Figure 27: Global Vagus Nerve Stimulator Market Value Share Analysis, by Region, 2021 and 2031
Figure 28: Global Vagus Nerve Stimulator Market Attractiveness, by Region, 2022-2031
Figure 29: North America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031
Figure 30: North America Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 31: North America Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 32: North America Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031
Figure 33: North America Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031
Figure 34: North America Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031
Figure 35: North America Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031
Figure 36: North America Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 37: North America Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031
Figure 38: North America Vagus Nerve Stimulator Market Analysis and Forecast, by Country, 2021 and 2031
Figure 39: North America Vagus Nerve Stimulator Market Attractiveness Analysis, by Country, 2022–2031
Figure 40: Europe Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031
Figure 41: Europe Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 42: Europe Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 43: Europe Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031
Figure 44: Europe Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031
Figure 45: Europe Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031
Figure 46: Europe Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031
Figure 47: Europe Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 48: Europe Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031
Figure 49: Europe Vagus Nerve Stimulator Market Analysis and Forecast, Country/Sub-region, 2021 and 2031
Figure 50: Europe Vagus Nerve Stimulator Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 51: Asia Pacific Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031
Figure 52: Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 53: Asia Pacific Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 54: Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031
Figure 55: Asia Pacific Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031
Figure 56: Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031
Figure 57: Asia Pacific Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031
Figure 58: Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 59: Asia Pacific Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031
Figure 60: Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 61: Asia Pacific Vagus Nerve Stimulator Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 62: Latin America Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031
Figure 63: Latin America Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 64; Latin America Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 65: Latin America Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031
Figure 66: Latin America Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031
Figure 67: Latin America Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031
Figure 68: Latin America Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031
Figure 69: Latin America Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 70: Latin America Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031
Figure 71: Latin America Vagus Nerve Stimulator Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 72: Latin America Vagus Nerve Stimulator Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 73: Middle East & Africa Vagus Nerve Stimulator Market Value (US$ Mn) Forecast, 2017–2031
Figure 74: Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast, by Product Type, 2021 and 2031
Figure 75: Middle East & Africa Vagus Nerve Stimulator Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 76: Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast, by Biomaterial, 2021 and 2031
Figure 77: Middle East & Africa Vagus Nerve Stimulator Market Attractiveness Analysis, by Biomaterial, 2022–2031
Figure 78: Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast, by Application, 2021 and 2031
Figure 79: Middle East & Africa Vagus Nerve Stimulator Market Attractiveness Analysis, by Application, 2022–2031
Figure 80; Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast, by End-user, 2021 and 2031
Figure 81: Middle East & Africa Vagus Nerve Stimulator Market Attractiveness Analysis, by End-user, 2022–2031
Figure 82: Middle East & Africa Vagus Nerve Stimulator Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
Figure 83: Middle East & Africa Vagus Nerve Stimulator Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Vagus Nerve Stimulator Market
*86 figures and 60 tables includes